Genmab — Marts 2018
-
Bloomberg finally figuring out that "Hedge Funds Are Placing Record Bets That Danish Stocks Will Fall" - https://www.bloomberg.com/news/articles/2018-03-08/short-bets-soar-against-denmark-inc-in-trend-regulator-welcomes
-
Hej Mcjean, hvor har du mon tallet fra ?
-
JKY_VH og Mcjean,
-
ja det så jeg godt, men hvor dælen har Bloomberg tallene fra - Finanstilsynet offentliggør jo kun shorts der overstiger 0,5% og kan da ikke forestille mig at Bloomberg har insiderviden ??
-
Såvidt jeg kan se offentliggør finanstilsynet summen af alle shorts https://www.finanstilsynet.dk/da/Lovgivning/Information-om-udvalgte-tilsynsomraader/Short-selling/Offentliggjorte-positioner . Ultimo feb 3.58% i Gen ?
-
Abstract Journal of Immunotherapy - A Dose-escalation Study of Recombinant Human Interleukin-18 in Combination With Ofatumumab After Autologous Peripheral Blood Stem Cell Transplantation for Lymphoma - https://www.ncbi.nlm.nih.gov/pubmed/29517616?dopt=Abstract
-
Maybe linked to this old trial? - https://clinicaltrials.gov/ct2/show/NCT01768338
-
peter12, tak for info - den var jeg ikke lige opmærksom på - med min simple regnemaskine kommer jeg frem til en short-posotion på i alt ca. 456 mio $ eller ca. 77% af det som Bloomberg offentliggør - måske de "sjusser" sig til ca. 1/3 oveni for shorts under 0,2%
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind